Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.
about
CRISPR/Cas9-The ultimate weapon to battle infectious diseases?CRISPR Editing Technology in Biological and Biomedical Investigation.Novel AIDS therapies based on gene editing.HIV Reservoir Characterization Symposium: 19 September 2016, Ghent, Belgium.Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants.Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era.The Future of Multiplexed Eukaryotic Genome Engineering.Genome editing technologies to fight infectious diseases.Digital PCR as a tool to measure HIV persistence.Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.The CRISPR tool kit for genome editing and beyond.Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant formsComprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling
P2860
Q36196813-EA4E293B-D549-4D74-9A82-227FCFF6D527Q38688945-D59D1256-0E47-4A23-A974-34E85BB33AC2Q39140209-E1606030-28DD-4788-AFD5-39E802558350Q42318284-304016B4-6268-4249-907F-37042FD97F02Q43212335-763551C0-D29F-4C1B-B00F-2294591EBFD2Q45875539-4900BBDD-16C7-4178-BF7F-90883B1CF74CQ47249662-BF79D08E-E713-440B-9707-A2DD4D3F11E9Q47392998-88BE23AC-D33C-4D12-80B3-FA6FC37BE75EQ47548213-EC53F13D-48C7-4393-BF9A-9C7A9F8DB54FQ52431127-9662F438-B294-4698-B68F-8DEEC9B4DFDDQ55233775-01DDBD0D-4A9C-4B7E-B930-DB4328EAE824Q58128506-E03523C6-7324-47A1-87B0-48541C325D20Q58755636-8A127146-CB92-4942-88E2-30CC300F6A01
P2860
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeted HIV-1 Latency Reversa ...... scriptional Activator Systems.
@ast
Targeted HIV-1 Latency Reversa ...... scriptional Activator Systems.
@en
type
label
Targeted HIV-1 Latency Reversa ...... scriptional Activator Systems.
@ast
Targeted HIV-1 Latency Reversa ...... scriptional Activator Systems.
@en
prefLabel
Targeted HIV-1 Latency Reversa ...... scriptional Activator Systems.
@ast
Targeted HIV-1 Latency Reversa ...... scriptional Activator Systems.
@en
P2093
P2860
P1433
P1476
Targeted HIV-1 Latency Reversa ...... scriptional Activator Systems.
@en
P2093
Carola Schäfer
Gábor A Dunay
Joachim Hauber
Julia K Bialek
Maike Voges
Michael Spohn
Rolf Stucka
Ulrike C Lange
P2860
P304
P356
10.1371/JOURNAL.PONE.0158294
P407
P577
2016-06-24T00:00:00Z